{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:31:31Z","timestamp":1779111091509,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.det.2018.12.004","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:08:22Z","timestamp":1550102902000},"page":"143-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["What's New in Nail Disorders"],"prefix":"10.1016","volume":"37","author":[{"given":"Austin J.","family":"Maddy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Tosti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.det.2018.12.004_bib1","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s40265-016-0564-5","article-title":"Nail psoriasis: a review of treatment options","volume":"76","author":"Pasch","year":"2016","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.det.2018.12.004_bib2","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/bjd.12060","article-title":"A\u00a024-week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis","volume":"168","author":"Ortonne","year":"2013","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2018.12.004_bib3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaad.2017.08.029","article-title":"Adalimumab for nail psoriasis: efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial","volume":"78","author":"Elewski","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.det.2018.12.004_bib4","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s40265-015-0439-1","article-title":"Apremilast: a review in psoriasis and psoriatic arthritis","volume":"75","author":"Deeks","year":"2015","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.det.2018.12.004_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jaad.2015.03.049","article-title":"Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: results of a phase III, randomized, controlled trial (efficacy and safety trial evaluating the effects of apremilast in psoriasis [ESTEEM] 1)","volume":"73","author":"Papp","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2018.12.004_bib6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaad.2015.09.001","article-title":"Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2)","volume":"74","author":"Rich","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2018.12.004_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaad.2017.01.053","article-title":"Efficacy of tofacitinib for the treatment of nail psoriasis: two 52-week, randomized, controlled phase 3 studies in patients with moderate-to-severe plaque psoriasis","volume":"77","author":"Merola","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2018.12.004_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000434686","article-title":"Severe onychodystrophy due to allergic contact dermatitis from acrylic nails","volume":"1","author":"Mattos Simoes Mendonca","year":"2015","journal-title":"Skin Appendage Disord"},{"issue":"4","key":"10.1016\/j.det.2018.12.004_bib9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/cod.12942","article-title":"Allergic contact dermatitis caused by nail acrylates in Europe. An EECDRG study","volume":"78","author":"Gon\u00e7alo","year":"2018","journal-title":"Contact Dermatitis"},{"issue":"1","key":"10.1016\/j.det.2018.12.004_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/jdv.14603","article-title":"Pterygium inversum unguis secondary to gel polish","volume":"32","author":"Cervantes","year":"2018","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.det.2018.12.004_bib11","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1111\/pde.13429","article-title":"Retronychia a little-known cause of paronychia: a report of two cases in adolescent patients","volume":"35","author":"Poveda-Montoyo","year":"2018","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.det.2018.12.004_bib12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.7547\/16-152","article-title":"Retronychia","volume":"108","author":"Nakouri","year":"2018","journal-title":"J\u00a0Am Podiatr Med Assoc"},{"issue":"4","key":"10.1016\/j.det.2018.12.004_bib13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/09546634.2017.1395799","article-title":"Biotin for the treatment of nail disease: what is the evidence?","volume":"29","author":"Lipner","year":"2018","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1016\/j.det.2018.12.004_bib14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.clinbiochem.2018.01.018","article-title":"Assessment of biotin interference with qualitative point-of-care hCG test devices","volume":"53","author":"Williams","year":"2018","journal-title":"Clin Biochem"},{"key":"10.1016\/j.det.2018.12.004_bib15","doi-asserted-by":"crossref","DOI":"10.1159\/000488440","article-title":"Is biotin safe for dermatology patients?","author":"Rigopoulos","year":"2018","journal-title":"Skin Appendage Disord"},{"issue":"4","key":"10.1016\/j.det.2018.12.004_bib16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/jocd.12393","article-title":"Oral supplementation with specific bioactive collagen peptides improves nail growth and reduces symptoms of brittle nails","volume":"16","author":"Hexsel","year":"2017","journal-title":"J\u00a0Cosmet Dermatol"},{"issue":"2","key":"10.1016\/j.det.2018.12.004_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.det.2014.12.001","article-title":"Tips to treat the 5 most common nail disorders","volume":"33","author":"Iorizzo","year":"2015","journal-title":"Dermatol Clin"},{"issue":"1","key":"10.1016\/j.det.2018.12.004_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1473-2165.2007.00290.x","article-title":"Nail cosmetics in nail disorders","volume":"6","author":"Iorizzo","year":"2007","journal-title":"J\u00a0Cosmet Dermatol"},{"issue":"2","key":"10.1016\/j.det.2018.12.004_bib19","first-page":"1013","article-title":"Effects of a novel nail lacquer based on hydroxypropyl-Chitosan (HPCH) in subjects with fingernail onychoschizia","volume":"2","author":"Sparavigna","year":"2014","journal-title":"J\u00a0Dermatol Clin Res"},{"key":"10.1016\/j.det.2018.12.004_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2018.04.015","article-title":"Dermoscopic features of onychotillomania: a study of 36 cases","author":"Maddy","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2018.12.004_bib21","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/j.jaad.2017.06.154","article-title":"Onychophagia and onychotillomania can be effectively managed","volume":"77","author":"Magid","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2018.12.004_bib22","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jaad.2016.05.036","article-title":"Onychotillomania: an underrecognized disorder","volume":"75","author":"Rieder","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2018.12.004_bib23","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s40257-017-0289-6","article-title":"Onychotillomania: diagnosis and management","volume":"18","author":"Halteh","year":"2017","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"10.1016\/j.det.2018.12.004_bib24","first-page":"334","article-title":"Medical tattooing, the new frontiers: a case of nail bed treatment","volume":"53","author":"Renzoni","year":"2017","journal-title":"Ann Ist Super Sanita"},{"key":"10.1016\/j.det.2018.12.004_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.15024","article-title":"Alitretinoin can be a good treatment option for idiopathic recalcitrant trachyonychia in adults: an open-label study","author":"Shin","year":"2018","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.det.2018.12.004_bib26","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s10067-017-3574-0","article-title":"Recovery of nail dystrophy potential new therapeutic indication of tofacitinib","volume":"36","author":"Jaller","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.det.2018.12.004_bib27","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000450848","article-title":"Remarkable improvement of nail changes in alopecia areata universalis with 10 months of treatment with Tofacitinib: a case report","volume":"8","author":"Ferreira","year":"2016","journal-title":"Case Rep Dermatol"},{"issue":"4","key":"10.1016\/j.det.2018.12.004_bib28","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1001\/jamadermatol.2015.3772","article-title":"Tofacitinib citrate for the treatment of nail dystrophy associated with alopecia universalis","volume":"152","author":"Dhayalan","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2018.12.004_bib29","first-page":"1","article-title":"Nail involvement in\u00a0patients with moderate-to-severe alopecia areata\u00a0treated with oral tofacitinib","author":"Lee","year":"2018","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"4","key":"10.1016\/j.det.2018.12.004_bib30","doi-asserted-by":"crossref","first-page":"371","DOI":"10.5021\/ad.2015.27.4.371","article-title":"Efficacy and safety of calcipotriol\/betamethasone dipropionate ointment for the treatment of trachyonychia: an open-label study","volume":"27","author":"Park","year":"2015","journal-title":"Ann Dermatol"},{"issue":"9","key":"10.1016\/j.det.2018.12.004_bib31","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.bjps.2010.12.021","article-title":"Treatment options for cutaneous pyogenic granulomas: a review","volume":"64","author":"Lee","year":"2011","journal-title":"J\u00a0Plast Reconstr Aesthet Surg"},{"issue":"5","key":"10.1016\/j.det.2018.12.004_bib32","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1365-2133.2010.09906.x","article-title":"Periungual and subungual pyogenic granuloma","volume":"163","author":"Piraccini","year":"2010","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2018.12.004_bib33","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/jdv.13071","article-title":"Topical propranolol 1% cream for pyogenic granulomas of the nail: open-label study in 10 patients","volume":"30","author":"Piraccini","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.det.2018.12.004_bib34","first-page":"1353","article-title":"Photodynamic therapy for periungual pyogenic granuloma-like during chemotherapy: our preliminary results","volume":"26","author":"Fabbrocini","year":"2018","journal-title":"Support Care Cancer"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386351831146X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386351831146X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:41:58Z","timestamp":1760006518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073386351831146X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S073386351831146X"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2018.12.004","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What's New in Nail Disorders","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2018.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}